NCT05060991View on ClinicalTrials.gov

Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 24, 2021

Primary Completion Date

December 24, 2025

Study Completion Date

December 24, 2025

Conditions
COVID-19ImmunosuppressionVaccine Response Impaired
Interventions
DRUG

Reduction in antimetabolite immunosuppression

Reduction in dose in mycophenolate mofetil/mycophenolic acid (MMF) or azathioprine before and after receiving 3rd dose vaccination

Trial Locations (1)

95817

RECRUITING

University of California, Davis, Sacramento

Sponsors

Collaborators (1)

CareDx
All Listed Sponsors
collaborator

CareDx

INDUSTRY

lead

University of California, Davis

OTHER

NCT05060991 - Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter